In INTerpath-001, the combination of adjuvant Intismeran plus pembro is superior to pembro alone in resected melanoma mproves RFS in ITT 70% vs 82.2% HR 0.58 #ESMO2026 @darioT_ @my

Abeid Athman (Omar).· @bin_abeid · X·2026-10-24 22:55· 14 小时前评分70

正文 · 原文

In INTerpath-001, the combination of adjuvant Intismeran plus pembro is superior to pembro alone in resected melanoma mproves RFS in ITT 70% vs 82.2% HR 0.58 #ESMO2026 @darioT_ @myESMO @DrChoueiri @FAndreMD @OncoAlert

31 浏览 · 2 赞 · 0 转发 · 0 回复

会议摘要

LBA1按 Presidential Symposium I 对上

INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)

https://esmocongress.esmo.org

NCT05933577NCT05933577按 INTerpath-001 对上

INTerpath-001

https://esmocongress.esmo.org

来源：Abeid Athman (Omar). · x.com